Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare Biotechnology

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc

Bullboard Posts

Comment by Stylesson Jun 08, 2014 11:20pm

208 Views

Post# 22641725

RE:You Are out to lunch

Take the cash on the balance sheet + 100M for the voucher and divide that by the current shares out.

Tell me what you get.

IF you get anywhere close to 5.80, do it again.ha

I'm being very generous ascrbing a 100M for the voucher. I personally don't think it's worth that much.

Bullboard Posts

The top 5 Canadian small-cap AI stocks